Product Details for: Lynozyfic

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
5MG/2.5ML (2MG/ML)
Single-Dose Vial
351(a)
Lynozyfic
Rx
002
Injection
Intravenous
200MG/10ML (20MG/ML)
Single-Dose Vial
351(a)
Lynozyfic
Rx
Proper Name
linvoseltamab-gcpt
BLA Number
761400
Applicant
Regeneron Pharmaceuticals, Inc.
Original Approval Date
July 2, 2025
Date of First Licensure
RETURN TO SEARCH RESULTS